OSR Health, Inc. OSRH
0.23
(0.03)
(11.54%)
as of 25 Sep
- Market cap
- $4.1M
- P/E
- 0.0×
Follow OSRH
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (14.98%) | (14.32%) | (20.03%) | (22.63%) |
+8 more TTM periods Free account |
|
| (11.24%) | (10.73%) | (15.62%) | (16.39%) | ||
ROIC |
(8.19%) | (9.12%) | (8.84%) | (6.22%) | |
Return on Tangible Assets |
155.41% | 125.48% | 190.83% | 123.85% | |
Average Days of Receivables |
49.26 | 44.39 | 49.25 | 56.65 | |
Free Cash Flow per Share |
(0.22) | (0.17) | (0.24) | (0.16) | |
Free Cash Flow |
(7.20) | (5.27) | (4.76) | (3.44) | |
Capital Expenditures |
— | — | (0.43) | 0.00 | |
Piotroski F-Score |
4.00 | 3.00 | 1.00 | 1.00 | |
| Other line items | |||||
Cash ROIC |
(5.46%) | (3.93%) | (3.25%) | (2.44%) | |
Accounts Receivable Turnover |
3.63 | 4.70 | 4.38 | 0.00 | |
Accounts Payable Turnover |
0.15 | 0.26 | 0.52 | 0.63 | |
Inventory Turnover |
2.95 | 3.41 | 4.14 | 0.00 | |
Average Days of Payables |
2,496.34 | 1,475.39 | 1,235.67 | 993.14 | |
Days of Inventory on Hand |
185.32 | 82.59 | 30.99 | 23.99 | |
Tax Rate |
(0.15) | (0.13) | (0.08) | (0.12) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
969.01% | 748.30% | 651.42% | 412.43% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.36 | 0.28 | 0.16 | 0.24 | |
Depreciation/Fixed assets |
66.55 | 61.62 | 55.03 | 83.23 | |
Capex/Depreciation |
0.00 | 0.00 | (0.05) | 0.00 | |
Revenue per Share |
0.06 | 0.08 | 0.15 | 0.16 | |
Operating CF per Share |
(0.22) | (0.17) | (0.22) | (0.16) | |
Capex per Share |
0.00 | 0.00 | (0.02) | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.15 | 0.00 | |
Net Profit Margin |
(1,093.41%) | (707.50%) | (931.19%) | (422.34%) |
Columns are period end dates